Neena Kadaba
Directeur/Bestuurslid bij Eyevensys SAS
Profiel
Neena Kadaba is currently a Director at Eyevensys SAS since 2020.
Prior to this, she worked as a Partner at Mission Bay Capital Management, Inc. from 2014 to 2015.
Dr. Kadaba completed her undergraduate and graduate degrees from Massachusetts Institute of Technology in 2003 and received her doctorate degree from California Institute of Technology in 2008.
Actieve functies van Neena Kadaba
| Bedrijven | Functie | Begin |
|---|---|---|
Eyevensys SAS
 Eyevensys SAS Miscellaneous Commercial ServicesCommercial Services Eyevensys SAS develops non-viral gene therapy process for the treatment of ocular illnesses. The firm's process enables prolonged production of all therapeutic proteins through electrotransfer. Its product, the single-used device is designed for treating ocular illnesses. The company was founded by Francine Behar-Cohen on December 8, 2008 and is headquartered in Paris, France. | Directeur/Bestuurslid | 08-01-2020 |
Eerdere bekende functies van Neena Kadaba
| Bedrijven | Functie | Einde |
|---|---|---|
Mission Bay Capital Management, Inc.
 Mission Bay Capital Management, Inc. Investment ManagersFinance Mission Bay Capital Management Inc (Mission Bay Capital) is a venture capital firm founded in 2009. The firm is headquartered in San Francisco, California. | Private Equity Investor | 31-12-2015 |
Opleiding van Neena Kadaba
| Massachusetts Institute of Technology | Graduate Degree |
| California Institute of Technology | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 2 |
|---|---|
Mission Bay Capital Management, Inc.
Mission Bay Capital Management, Inc. Investment ManagersFinance Mission Bay Capital Management Inc (Mission Bay Capital) is a venture capital firm founded in 2009. The firm is headquartered in San Francisco, California. | Finance |
Eyevensys SAS
Eyevensys SAS Miscellaneous Commercial ServicesCommercial Services Eyevensys SAS develops non-viral gene therapy process for the treatment of ocular illnesses. The firm's process enables prolonged production of all therapeutic proteins through electrotransfer. Its product, the single-used device is designed for treating ocular illnesses. The company was founded by Francine Behar-Cohen on December 8, 2008 and is headquartered in Paris, France. | Commercial Services |